The results were consistent and sobering: Within one year of stopping, participants regained about two-thirds of the weight they had lost
Compared to other otopathogens, NTHi-associated OM is associated with higher disease severity, treatment failure, recurrence, persistence and need for repeat surgery (Seppanen et al., 2020)
In addition, the evidence that oral semaglutide can significantly improve not only glycaemic control and body weight but also cardiovascular risk factors (including blood pressure, lipids and inflammation), supports a cardioprotective action [6]
Godlewska BR, Clare S, Cowen PJ, Emir UE
Wyatt, L
Virtual Provider Appointments: Our weight loss program in Brooklyn, New York facilitates virtual appointments with physicians and licensed providers, eliminating the need for office visits